id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-1429-0011,FDA,FDA-2013-N-1429,"Registration of Human Drug Compounding Outsourcing Facilities
Under Section 503B of the FD&C Act; Final Guidance for Industry; Availability",Notice,Notice of Availability,2014-11-24T05:00:00Z,2014,11,2014-11-24T05:00:00Z,,2020-04-23T20:13:48Z,2014-27693,0,0,090000648194152e
FDA-2013-N-1429-0012,FDA,FDA-2013-N-1429,Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act Guidance for Industry,Other,Guidance,2014-11-24T05:00:00Z,2014,11,2014-11-24T05:00:00Z,,2024-11-12T05:34:14Z,,1,0,0900006481942653
FDA-2013-N-1429-0010,FDA,FDA-2013-N-1429,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Guidance for
Industry on Registration of Human Drug Compounding Outsourcing
Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act",Notice,General Notice,2014-08-27T04:00:00Z,2014,8,2014-08-27T04:00:00Z,2014-09-27T03:59:59Z,2014-08-29T01:04:50Z,2014-20276,0,0,0900006481847c04